Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Eric Li, MD

Advertisement

Articles by Eric Li, MD

Prostate cancer cells | Image Credit: © Dr_Microbe - stock.adobe.com

Expert: PSMA-PET should be considered at lower PSA levels

ByEric Li, MD
November 28th 2024
Eric Li, MD, answers a question during a Zoom video interview

Eric Li, MD, on PSMA-PET imaging in men with low PSA levels

ByEric Li, MD
November 12th 2024

"We found that almost half of them had suspicious findings as defined by the radiologist, but also that the positivity rate for PSAs below 0.5 were around 35%," says Eric Li, MD.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Urology Times

    1

    FDA approves sildenafil oral film for men with erectile dysfunction

    2

    The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD

    3

    Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC

    4

    Pearls & Perspectives: Modern Semen Testing and Male Fertility Care, with Thomas Masterson, MD

    5

    URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Job Board
    • Terms and Conditions
    • Privacy
    • Do not sell my Personnal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us